Sign in
4

Changes in Ownership

PMV Pharmaceuticals, Inc. Filed Acc 0001209191-20-065683

COO, CFO acquired 1,600 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Kung Winston COO, CFO 2020-12-08 Option exercise +1,600 $3.22 $5,152 1,600 D
Derivatives
Kung Winston COO, CFO 2020-12-08 Option exercise · Stock Option (right to buy) −1,600 237,034 D
Loading xslF345X03/doc4.xml…